TITLE

Aspirin could save lives

PUB. DATE
September 1993
SOURCE
Science Teacher;Sep93, Vol. 60 Issue 6, p12
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Reports on the potential of aspirin to prevent fatal heart attacks. Estimated heart attack fatalities in the U.S. and those that could be saved by aspirin; Drop in death rate among patients; Request of the Aspirin Strategy Group to the Food and Drug Administration for broader labeling of aspirin.
ACCESSION #
9311243694

 

Related Articles

  • Monday morning MIs. Donaldson Jr., Robert M.; Berkowitz, Henry D. // Cortlandt Forum;7/25/95, Vol. 8 Issue 7, p77 

    Discusses the preventive effects of aspirin on myocardial infarction. Avoiding weekend absence of aspirin; Time span of antiplatelet effects of a dose of aspirin.

  • Aspirin for Primary Prevention of Coronary Events. Lauer, Michael S. // New England Journal of Medicine;5/9/2002, Vol. 346 Issue 19, p1468 

    Focuses on the use of aspirin for primary prevention of coronary events such as myocardial infarction, highlighted through the case vignette of a 45-year old man with a strong family history of premature heart disease. Strategies and evidence; Areas of uncertainty; Guidelines; Conclusions and...

  • Aspirin and warfarin best for primary prevention of heart... Kmietowicz, Zosia // BMJ: British Medical Journal (International Edition);01/31/98, Vol. 316 Issue 7128, p330 

    Details the study of the Medical Research Council on the effectiveness of warfarin and aspirin on preventing heart attacks. Methodology used in the study; Findings of the study; Account on the warning given by Freek Verheught, professor from the University Hospital of Nijmegen, on aspirin and...

  • Could recommendations about aspirin prophylaxis enhance colorectal cancer screening programmes? Morgan, Gareth; Elwood, Peter // European Journal of Public Health;Dec2009, Vol. 19 Issue 6, p576 

    The article analyzes a study which examined the effectiveness of aspirin prophylaxis in enhancing colorectal cancer screening programmes. The health benefits of aspirin are noted, including reducing the risk of vascular events and myocardial infarction. The study observed that the benefits of...

  • FACT OR FICTION.  // Newsweek (Pacific Edition);10/30/2006 (Pacific Edition), Vol. 148 Issue 18, following p8 

    This article reports on a new study that suggests aspirin may harm the stomach and upper digestive tract. The article asks if the benefits of aspirin outweigh the dangers. The answer could be no because aspirin causes 150 more cases of GI complications per 1,000 people in male patients in their...

  • Give blood, live longer. Day, Michael // New Scientist;10/17/98, Vol. 160 Issue 2156, p15 

    Focuses on research that found evidence that men who donate blood are less likely to have a heart attack than those who are not blood donors. Study at University of Kuopio, Finland, by Jukka Salonen; Description of the study; Possible selection bias; Support of earlier findings that people with...

  • Analysis of cost-effectiveness of antidyslipidemic therapy for preventing myocardial infarction... Haynes, R. Brian // Cortlandt Forum;07/25/97, Vol. 10 Issue 7, p22 

    Discusses the use of antidyslipidemic therapy for the prevention of myocardial infarction (MI) and death in the United States. Debate over the effects of lowering elevated lipids; Individual baseline risk; Risk of subsequent cardiovascular events after MI.

  • Clopidogrel in ischemic heart disease: A critical appraisal. Al-Otaiby, Mohammed A.; Al-Moghairi, Abdulrahman M. // Health (1949-4998);Mar2013, Vol. 5 Issue 3, p465 

    Aspirin and clopidogrel are the commonest dual antiplatelet agents being used in the secondary prevention of cardiovascular disease. In high risk patients with coronary heart disease, the use of aspirin was associated with a significant risk reduction of myocardial infarction, stroke and...

  • Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials Sanmuganathan, P S; Ghahramani, P; Jackson, P R; Wallis, E J; Ramsay, L E // Heart;Mar2001, Vol. 85 Issue 3, p265 

    The article presents a study which investigates the safety and benefit of aspirin used as primary prevention of coronary heart disease. The study was conducted through meta-analysis of four randomised controlled trials of aspirin. The study reveals that aspirin used in preventing coronary heart...

  • Lifestyle changes reduce cardiovascular risk. Ryan, Patricia // Research Review (International Council on Active Aging);Apr2012, Vol. 12 Issue 13, p4 

    The article discusses the results of Heart of New Ulm Project, aimed at reducing heart attacks and coronary heart disease in New Ulm, Minnesota, that found reductions in factors including smoking, stress levels and hypertension, as well as in hyperlipidemia, and fasting glucose.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics